Ryght Joins Prestigious CancerX Program to Accelerate Innovation in Cancer Research
LAGUNA BEACH, Calif., July 17, 2024 /PRNewswire/ — Ryght, a leading enterprise generative AI (GenAI) technology company dedicated to improving clinical research, proudly announces its new partnership with CancerX, a public-private partnership aimed at boosting innovation in the fight against cancer.
CancerX, launched in February 2023 as part of the White House’s reinvigorated Cancer Moonshot, is a public-private partnership co-hosted by the Moffitt Cancer Center and the Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH). As a CancerX member, Ryght joins other leaders in oncology and digital health to set priorities and practices aimed at harnessing the full power of innovation to combat cancer.
